Cargando…
Using Prognosis-Related Gene Expression Signature and Connectivity Map for Personalized Drug Repositioning in Multiple Myeloma
BACKGROUND: Multiple myeloma (MM) is the second most common hematologic cancer with poor prognosis. Novel therapeutic strategies are needed to decrease the high mortality rate. The aim of this study was to identify prospective agents for MM. MATERIAL/METHODS: A microarray dataset was mined, which co...
Autores principales: | Zhu, Fang-xiao, He, Yu-chan, Zhang, Jun-yan, Wang, Hang-fei, Zhong, Chen, Wang, Xiao-tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510057/ https://www.ncbi.nlm.nih.gov/pubmed/31048671 http://dx.doi.org/10.12659/MSM.913970 |
Ejemplares similares
-
Connection between SOX7 Expression and Breast Cancer Prognosis
por: Qin, Chun-xin, et al.
Publicado: (2020) -
Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient
por: Tang, Jia, et al.
Publicado: (2019) -
Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis
por: Zhang, Xianfeng, et al.
Publicado: (2021) -
Baicalein Inhibits Proliferation of Myeloma U266 Cells by Downregulating IKZF1 and IKZF3
por: Liu, Xiao-Ping, et al.
Publicado: (2018) -
The Expression of Actin-Related Protein 2/3 Complex Subunit 5 (ARPC5) Expression in Multiple Myeloma and its Prognostic Significance
por: Xiong, Tao, et al.
Publicado: (2018)